Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes. Gyoutoku N, Inoguchi Y, Rikitake J, Demiya M, et al. PLoS One 2025;20:e0335888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gyoutoku N, Inoguchi Y, Rikitake J, Demiya M, et al. Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes. PLoS One 2025;20:e0335888.
PMID: 41171838